These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 18085392

  • 1. Evaluation of serum fetuin-A relationships with biochemical parameters in patients on hemodialysis.
    Oikawa O, Higuchi T, Yamazaki T, Yamamoto C, Fukuda N, Matsumoto K.
    Clin Exp Nephrol; 2007 Dec; 11(4):304-308. PubMed ID: 18085392
    [Abstract] [Full Text] [Related]

  • 2. What does the circulating AHSG/fetuin-A level tell us?
    Kazama JJ.
    Clin Exp Nephrol; 2007 Dec; 11(4):336-337. PubMed ID: 18085398
    [No Abstract] [Full Text] [Related]

  • 3. Association of serum fetuin-A and biochemical parameters in hemodialysis patients.
    Haddad M, Tajbakhsh R, Farajollahi M, Qorbani M, Besharat S, Joshaghani HR.
    Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):769-73. PubMed ID: 24969186
    [Abstract] [Full Text] [Related]

  • 4. Potential Correlation Between Circulating Fetuin-A and Pentraxin-3 With Biochemical Parameters of Calcification in Hemodialysis Patients.
    Hashemi J, Joshaghani HR, Akaberi A, Hesari Z, Ghanbari R, Mohammadzadeh M, Golshan AR.
    Arch Iran Med; 2017 Dec 01; 20(12):752-755. PubMed ID: 29664315
    [Abstract] [Full Text] [Related]

  • 5. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.
    Wang AY, Woo J, Lam CW, Wang M, Chan IH, Gao P, Lui SF, Li PK, Sanderson JE.
    Nephrol Dial Transplant; 2005 Aug 01; 20(8):1676-85. PubMed ID: 15899935
    [Abstract] [Full Text] [Related]

  • 6. Fetuin-A as a risk factor for mortality in hemodialysis patients.
    Pecovnik Balon B, Knehtl M, Bevc S, Jakopin E, Gorenjak M.
    Wien Klin Wochenschr; 2010 May 01; 122 Suppl 2():63-7. PubMed ID: 20517675
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum fetuin-A levels, QT dispersion and P dispersion in dialysis patients.
    Taskapan MC, Taskapan H, Comert M, Temel I, Yagmur J, Ulutas O.
    Ren Fail; 2013 May 01; 35(4):477-82. PubMed ID: 23438291
    [Abstract] [Full Text] [Related]

  • 11. Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients.
    Kirkpantur A, Altun B, Hazirolan T, Akata D, Arici M, Kirazli S, Turgan C.
    Artif Organs; 2009 Oct 01; 33(10):844-54. PubMed ID: 19681840
    [Abstract] [Full Text] [Related]

  • 12. Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin.
    Stenvinkel P, Wang K, Qureshi AR, Axelsson J, Pecoits-Filho R, Gao P, Barany P, Lindholm B, Jogestrand T, Heimbürger O, Holmes C, Schalling M, Nordfors L.
    Kidney Int; 2005 Jun 01; 67(6):2383-92. PubMed ID: 15882283
    [Abstract] [Full Text] [Related]

  • 13. Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry.
    Coen G, Ballanti P, Balducci A, Grandi F, Manni M, Mantella D, Pierantozzi A, Ruggeri M, Sardella D, Sorbo G, Bonucci E.
    Am J Kidney Dis; 2006 Jul 01; 48(1):106-13. PubMed ID: 16797392
    [Abstract] [Full Text] [Related]

  • 14. Effect of serum fibroblast growth factor-23, matrix Gla protein and Fetuin-A in predicting osteoporosis in maintenance hemodialysis patients.
    Wu Q, Xiao DM, Fan WF, Ye XW, Niu JY, Gu Y.
    Ther Apher Dial; 2014 Oct 01; 18(5):427-33. PubMed ID: 25196492
    [Abstract] [Full Text] [Related]

  • 15. Serum fetuin-A is associated with the components of MIAC(malnutrition, inflammation, atherosclerosis, calcification) syndrome in different stages of chronic kidney disease.
    Mutluay R, Konca Değertekin C, Işıktaş Sayılar E, Derici Ü, Gültekin S, Gönen S, Arınsoy ST, Sindel MŞ.
    Turk J Med Sci; 2019 Feb 11; 49(1):327-335. PubMed ID: 30761853
    [Abstract] [Full Text] [Related]

  • 16. Fetuin-mineral complex reflects extraosseous calcification stress in CKD.
    Hamano T, Matsui I, Mikami S, Tomida K, Fujii N, Imai E, Rakugi H, Isaka Y.
    J Am Soc Nephrol; 2010 Nov 11; 21(11):1998-2007. PubMed ID: 20947626
    [Abstract] [Full Text] [Related]

  • 17. Serum fetuin-A levels inversely correlate with the severity of arterial calcification in patients with chronic lower extremity atherosclerosis without renal disease.
    Szeberin Z, Fehérvári M, Krepuska M, Apor A, Rimely E, Sarkadi H, Széplaki G, Prohászka Z, Kalabay L, Acsády G.
    Int Angiol; 2011 Oct 11; 30(5):474-50. PubMed ID: 21804488
    [Abstract] [Full Text] [Related]

  • 18. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis.
    Shroff RC, Shah V, Hiorns MP, Schoppet M, Hofbauer LC, Hawa G, Schurgers LJ, Singhal A, Merryweather I, Brogan P, Shanahan C, Deanfield J, Rees L.
    Nephrol Dial Transplant; 2008 Oct 11; 23(10):3263-71. PubMed ID: 18463323
    [Abstract] [Full Text] [Related]

  • 19. Relation of serum fetuin-A levels to coronary artery calcium in African-American patients on chronic hemodialysis.
    Zheng S, de las Fuentes L, Bierhals A, Ash-Bernal R, Spence K, Slatopolsky E, Davila-Roman VG, Delmez J.
    Am J Cardiol; 2009 Jan 01; 103(1):46-9. PubMed ID: 19101228
    [Abstract] [Full Text] [Related]

  • 20. Factors associated with serum fetuin-A concentrations after long-term use of different phosphate binders in hemodialysis patients.
    Lin HH, Liou HH, Wu MS, Huang CC.
    BMC Nephrol; 2016 Mar 23; 17():33. PubMed ID: 27007989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.